Selection of a novel strain of christensenella minuta as a future biotherapy for crohn’s disease

HIGHLIGHTS

• who: Karima Relizani from the Universitu00e9 have published the research work: Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohnu2019s disease, in the Journal: Scientific Reports Scientific Reports of 30/03/2022
• what: This work was intended to select a C. minuta strain candidate as a future live biotherapeutic product using a method based on non-biased screening steps followed by in_vivo validation.
• how: For this the authors used a monolayer of human Caco-2 cells that constitute the gold standard in mimicking the human intestinal barrier (STEP . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.